
Marios Georgakis is a Physician-Scientist in Human Genetics & Drug Development, ranked #1 in Science & Academia (Genomics & Genetics) (Top 50%).
Last updated
Marios Georgakis is a physician-scientist leading a laboratory at LMU Munich. He publishes detailed analyses and commentary on human genetics, drug development, and cardiovascular disease, frequently sharing links to new research papers, genomic resources, and clinical trial results. His content focuses on translating complex genetic and biomedical findings into insights for therapeutic target identification and validation, often discussing topics like LDL cholesterol, atherosclerosis, obesity therapeutics, and pharmacogenomics. He maintains a Substack newsletter for long-form writing on these subjects.
Human genetics has long supported the principle that the earlier, longer, and deeper we reduce LDL-C, the more atherosclerosis we can prevent.
Favikon helps you find the right creators, analyze them in depth, reach out at scale, and track what works.